Skip to content

Comparison of Nonapick and Pidrolax for bowel preparation before colonoscopy

Comparison of sodium picosulfate magnesium oxide citric acid (Nonapick) versus polyethylene glycol for bowel preparation before colonoscopy: A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250807066785N1
Enrollment
60
Registered
2026-02-13
Start date
2023-05-02
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation for Colonoscopy.

Interventions

Intervention 1: Intervention group : Receiving Sodium Pico sulfate Magnesium Oxide Citric Acid (Nonapick, Nona Darou Pars) , 3 Sachets,16 grams each, with 4.5 litres of water , in divided doses the da

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Colonoscopy candidate outpatients attending the Gastrointestinal and Liver Disease Clinic

Exclusion criteria

Exclusion criteria: Glumerolar Filtration Rate lower than 30 Unwillingness to participate in the study Inability to pass the colonoscope through any part of the colon, for example due to mucosal lesions or strictures. History of colectomy

Design outcomes

Primary

MeasureTime frame
Quantified Bowel Preparation. Timepoint: Once, Upon Colonoscopy Procedure. Method of measurement: Based on Boston Bowel Preparation Scale.;Adverse Reactions. Timepoint: Once, On the day of colonoscopy procedure. Method of measurement: Based on Mayo Clinic Questionnaire of bowel preparation Adverse effects.;Treatment Tolerance. Timepoint: Once, On the day of colonoscopy procedure. Method of measurement: Participants are asked to choose one of 3 options in regards to Treatment Tolerance : Barely , Moderately or Well Tolerated.

Secondary

MeasureTime frame
Blood Urea Nitrogen. Timepoint: Twice, First within 14 days before colonoscopy as Base, And second on the day of colonoscopy. Method of measurement: Laboratory assessment ( Blood Sample ).;Serum Creatinine. Timepoint: Twice, First within 14 days before colonoscopy as Base, And second on the day of colonoscopy. Method of measurement: Laboratory assessment ( Blood Sample ).;Serum Sodium. Timepoint: Twice, First within 14 days before colonoscopy as Base, And second on the day of colonoscopy. Method of measurement: Laboratory assessment ( Blood Sample ).;Serum Potassium. Timepoint: Twice, First within 14 days before colonoscopy as Base, And second on the day of colonoscopy. Method of measurement: Laboratory assessment ( Blood Sample ).;Serum Calcium. Timepoint: Twice, First within 14 days before colonoscopy as Base, And second on the day of colonoscopy. Method of measurement: Laboratory assessment ( Blood Sample ).;Serum Phosphorus. Timepoint: Twice, First within 14 days before colonoscopy as Base, And second on the day of colonoscopy. Method of measurement: Laboratory assessment ( Blood Sample ).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahram Agah

Iran University of Medical Sciences

agah.sh@iums.ac.ir+98 21 6435 2358

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026